Strict rules have been laid down by the EU for the transport of temperature-controlled pharmaceutical products with its GDP guidelines, which mandate a reliable quality management system across the entire supply chain.
Schmitz Cargobull has said that its TrailerConnect telematics system has now been re-certified by TÜV Süd following a comprehensive audit, with the GDP certificate is valid for another two years.
Marnix Lannoije, managing director of Cargobull Telematics said: “After we were granted GDP certification by TÜV Süd for the first time in 2018, the feedback was very positive. Thanks to the certification of TrailerConnect, our customers were able to present an important certificate for their GDP audits, attesting the high quality and safety of our products.
“In addition, we were told by our customers that the GDP certificate is an essential element in obtaining authorisation for the transport of Covid-19 vaccines.”
The pharmaceuticals industry has been growing rapidly worldwide for many years. The transport volume and particularly the demand for end-to-end monitoring and documentation of the supply chain have been growing at the same time.
As a result, in 2013 the European Commission introduced guidelines on Good Distribution Practice (GDP) of medicinal products for human use for quality assurance and protection against counterfeit medicines. Manufacturers, pharmaceutical wholesalers and pharmacists must subject their processes to yearly GDP audits.
“With our GDP certificate we can document complete process reliability over the entire supply chain for our customers from the recording of data in the trailer and its storage through to its presentation in the portal or transmission in the API (interface for the transfer of data to third-party systems),” Lannoije added.
The certificate for the GDP audit can be requested from Schmitz Cargobull at any time, the company confirmed.